Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Wistar Institute
The Wistar Institute (/ˈwɪstɑːr/) is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease, and vaccine research. Located on Spruce Street in the University City section of Philadelphia, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.
Since 1972, Wistar has been a National Cancer Institute (NCI)-designated cancer center, and in that time, the Institute has established itself as a well-regarded research nonprofit. The NCI gave Wistar the highest cancer center rating of "exceptional" in two consecutive cancer center grant renewals in 2013 and 2018. Additionally, the Institute was ranked in 2024 in the 1st percentile for Innovation by the SCImago Institution Ranking (SIR) and third in US Research Institutions by Heartland Forward.
The Wistar Institute Cancer Center researches prevention, diagnosis and treatment of cancer. The center is organized in three research programs:
Wistar also maintains one of the largest melanoma research programs in the U.S. outside the National Institutes of Health (NIH). The Institute's significant cancer research findings include the identification of genetic alterations linked to the development of blood cancer; development of the monoclonal antibody technology and its development for clinical use; discovery of molecular markers for non-invasive diagnostic tests for lung cancer and cutaneous T-cell lymphoma; and the establishment of a Wistar melanoma cell line repository.
The Wistar Vaccine & Immunotherapy Center researches next-generation DNA-based technologies for prevention of infectious diseases — both viral and microbial — and for cancer immunotherapy.
The Institute's NIH-funded HIV-1 research program leads a consortium of several HIV investigators nationwide who develop and test combinations of novel immunotherapies in clinical trials.
Wistar's vaccine and immune research has resulted in the development of several significant vaccines:
The Institute offers several programs for education and training, including a postdoctoral program; joint graduate programs with select partnering institutions; student apprenticeships in biomedical research technician work; high school fellowships in biomedical research; and the Biomedical Technician Training Program, a joint venture between Wistar and the Community College of Philadelphia that trains community college students for work as research assistants and technicians.
Hub AI
Wistar Institute AI simulator
(@Wistar Institute_simulator)
Wistar Institute
The Wistar Institute (/ˈwɪstɑːr/) is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease, and vaccine research. Located on Spruce Street in the University City section of Philadelphia, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.
Since 1972, Wistar has been a National Cancer Institute (NCI)-designated cancer center, and in that time, the Institute has established itself as a well-regarded research nonprofit. The NCI gave Wistar the highest cancer center rating of "exceptional" in two consecutive cancer center grant renewals in 2013 and 2018. Additionally, the Institute was ranked in 2024 in the 1st percentile for Innovation by the SCImago Institution Ranking (SIR) and third in US Research Institutions by Heartland Forward.
The Wistar Institute Cancer Center researches prevention, diagnosis and treatment of cancer. The center is organized in three research programs:
Wistar also maintains one of the largest melanoma research programs in the U.S. outside the National Institutes of Health (NIH). The Institute's significant cancer research findings include the identification of genetic alterations linked to the development of blood cancer; development of the monoclonal antibody technology and its development for clinical use; discovery of molecular markers for non-invasive diagnostic tests for lung cancer and cutaneous T-cell lymphoma; and the establishment of a Wistar melanoma cell line repository.
The Wistar Vaccine & Immunotherapy Center researches next-generation DNA-based technologies for prevention of infectious diseases — both viral and microbial — and for cancer immunotherapy.
The Institute's NIH-funded HIV-1 research program leads a consortium of several HIV investigators nationwide who develop and test combinations of novel immunotherapies in clinical trials.
Wistar's vaccine and immune research has resulted in the development of several significant vaccines:
The Institute offers several programs for education and training, including a postdoctoral program; joint graduate programs with select partnering institutions; student apprenticeships in biomedical research technician work; high school fellowships in biomedical research; and the Biomedical Technician Training Program, a joint venture between Wistar and the Community College of Philadelphia that trains community college students for work as research assistants and technicians.